Feripon

Deferiprone INN

Composition : Deferiprone INN 500 mg Tablet.

Indication : Deferiprone is indicated for the treatment of iron overload patients with thalassemia major when deferoxamine therapy is contraindicated or inadequate. Deferiprone therapy should be initiated and maintained by a physician experienced in the treatment of patients with thalassemia.

Dosage and administration : In adults and children over 6 years : this medicine may be given by mouth in doses of 25mg/kg three times daily. Doses above 100mg/kg daily are not recommended. Or, as directed by the registered physician.

Use in pregnancy and lactation : Deferiprone is not recommended for use in pregnant & lactating women.

Packing : Feripon : 1x10's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.